A Four-Part Phase-1 Study Investigating the Tolerability, Safety and Pharmacokinetics (PK) of MBS2320 in Healthy Subjects and in Subjects With Rheumatoid Arthritis (RA) Also Treated With Methotrexate
Latest Information Update: 24 Dec 2021
At a glance
- Drugs Leramistat (Primary) ; Leramistat (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Istesso; Modern Biosciences
- 15 Jun 2019 Results presented at the 20th Annual Congress of the European League Against Rheumatism
- 24 Mar 2017 Status changed from recruiting to completed.
- 10 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 May 2017.